NCT00467974View on ClinicalTrials.gov

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

TEA with LEM

Transarterial ethanol ablation (TEA) with Lipiodol-ethanol mixture (LEM)

PROCEDURE

TACE

Transarterial chemoembolisation (TACE)

Trial Locations (3)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

Department of Diagnostic Radiology and Organ Imaging, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00467974 - Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter